Effects of Rifampin on the Pharmacokinetics of Ataluren
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This will be a single centre, Phase I, open-label, one cohort, one dose level,
fixed-sequence, drug interaction study in healthy volunteers. The objective of this study is
to determine the effects of rifampin on the pharmacokinetics of ataluren under fasting
conditions.